IHHN Signs Strategic MoU with PharmEvo to Drive Innovation and Research in Healthcare

Karachi, September 26, 2025, Indus Hospital & Health Network (IHHN) and PharmEvo have signed a Memorandum of Understanding (MoU) to promote academic research and enhance research capacity in clinical settings.

As part of this collaboration, PharmEvo will provide a Research Associate for IHHN’s Department of Internal Medicine. The initiative underscores both organizations’ shared commitment to fostering a robust research ecosystem that supports innovation and advances in healthcare.

The signing ceremony was attended by senior leadership from both institutions. Dr. Syed Zafar Zaidi, CEO of IHHN, signed the MoU alongside Dr. Abdul Bari Khan, President of IHHN, and Dr. Ashar Alam, Medical Director of IHHN. Representing PharmEvo, CEO Syed Jamshed Ahmed formalized the partnership.

Speaking on the occasion, the leadership of both organizations reaffirmed their dedication to building a culture of research and collaboration that benefits patients, healthcare providers, and the broader medical community.

This partnership marks another milestone in IHHN’s ongoing mission to integrate research and innovation into its clinical practice, thereby improving patient outcomes and strengthening Pakistan’s healthcare system.